Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...

it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea.

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

The history of antibiotic resistance in Staphylococcus aureus spans more than half a century. Methicillin-resistant S. aureus (MRSA) has emerged as an almost ubiquitous pathogen in both the ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria highly resistant to common antibiotics. Around 1 in 3 people carry the bacteria on their skin or inside their noses.

and it is the only FDA-approved methicillin-resistant Staphylococcus aureus (MRSA) cephalosporin antibiotic for treating adult patients with Staphylococcus aureus bloodstream infections ...

In 1962, the first case of methicillin-resistant Staphylococcus aureus (MRSA) was identified. Resistance of certain bacteria to other antibiotics was also reported. For several decades starting in the ...

Staphylococcus Aureus also known as staph is a bacteria ... a more aggressive strain resistant to many antibiotics. When working out in a public gym, make sure you use hand sanitiser and wet ...

Armata Pharmaceuticals ( (ARMP) ) has issued an announcement.

MRSA - or methicillin resistant staphylococcus aureus - has already become resistant to most common antibiotics, making it difficult to treat with drugs. Once it gets into the body, through wounds ...